Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Letter/Comment
In September 2019, FDA announced its
Press Releases
CHICAGO, July 23, 2020 — In partnership with the Association for Health Care Resource & Materials Management (AHRMM) of the American Hospital A
Podcasts
Learn how UCHealth was able to rapidly change and improve their inventory methods throughout the COVID-19 pandemic and how you can apply these…
Podcasts
Discover how a Medical Logistics Crisis Action Team could help your institution quickly organize efforts and resources in addition to your Incident…
Toolkits/Methodology
The Unique Device Identifier (UDI) is comprised of 2 segments: